Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-22-009627)

Filing Details

Accession Number:: 0001493152-22-009627
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-04-11 18:05:21
Reporting Period:: 2022-03-10

Accepted Time:: 2022-04-11 18:05:21
Original Submission Date:: 2022-03-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
868278	Prophase Labs Inc.	PRPH	Pharmaceutical Preparations (2834)	232577138

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645550	Michael Jason Barr	711 Stewart Avenue, Suite 200 Garden City, NY 11530		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0005	Acquisiton	2022-03-10	721	$6.48	30,962	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program.
The original Form 4 filed on March 16, 2022 mistakenly reported that the Reporting Person acquired 750 shares pursuant to an automatic broker-administered dividend reinvestment program.